-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK CSO: INTENTION IS TO FILE ZENAGAMTIDE AS BIOLOGICS LICENSE APPLICATION (BLA)

Reuters·09/21/2026 14:26:39

Please log in to view news